オプションチェーンは、iQIYIの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、iQIYIの市場センチメントを評価します。.

iQIYI (NASDAQ:IQ) 株価情報, オプションチェーン

IQIYI INC-ADR

iQIYI

Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.

iQIYI Inc

Everipedia

IQ-AI Ltd

FlexShares Trust Intl Quality Dividend Defensive Index Fd

FlexShares International Quality Dividend Index Fund

WisdomTree International Quality Dividend Growth Fund

FlexShares International Quality Dividend Dynamic Index Fund

IQE PLC

IQGeo Group PLC

NYLI MacKay High Income ETF

Invesco Quality Municipal Income Trust Common Stock

Invesco Quality Municipal Income Trust

IndexIQ ETF Trust NYLI 500 International ETF

iShares MSCI Intl Quality Factor ETF

Franklin Intelligent Machines ETF

IQeon

Inteliqo Ltd

ProShares Nasdaq-100 High Income ETF

NYLI CBRE Real Assets ETF

NYLI Candriam International Equity ETF

NYLI Candriam U.S. Mid Cap Equity ETF

iQSTEL Inc

NYLI Candriam U.S. Large Cap Equity ETF

IQVIA Holdings Inc

iQ International AG

WIIM

USIO

Usio shares are trading lower after the company reported mixed Q1 financial results.

Edesa Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDSA#NASDAQ">EDSA</a>) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.29) by 3.45 percent. This is a 48.28 percent increase over losses of $(0.58) per share from the same period last year.

Earnings

Earnings Misses

News

EDSA

Edesa Biotech Q2 EPS $(0.30) Misses $(0.29) Estimate

SILO

Silo Pharma shares are trading lower. The company announced  it has engaged Veloxity Labs for bioanalysis supporting the ongoing investigational new drug-enabling GLP-compliant toxicology and toxicokinetics study of SPC-15.

Enliven Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELVN#NASDAQ">ELVN</a>) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.49) by 16.33 percent. This is a 5.56 percent decrease over losses of $(0.54) per share from the same period last year.

ELVN

Enliven Therapeutics Q1 EPS $(0.57) Misses $(0.49) Estimate

AEON

AEON Biopharma Q1 EPS $2.28 Up From $(227.87) YoY

The Oncology Institute shares are trading higher after the company reported a year-over-year increase in Q1 financial results.

Steris (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STE#NYSE">STE</a>) is looking for FY2026 GAAP EPS of $7.82-$8.07 vs $7.87 analyst estimate..

Guidance

Steris Sees FY2026 GAAP EPS $7.82-$8.07 vs $7.87 Est

Steris (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STE#NYSE">STE</a>) is looking for FY2026 Adj EPS of $9.90-$10.15 vs $9.87 analyst estimate..

Steris Sees FY2026 Adj EPS $9.90-$10.15 vs $9.87 Est

Intelligent Protection Management shares are trading higher after the company reported better-than-expected Q1 EPS results.

Verde Clean Fuels (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VGAS#NASDAQ">VGAS</a>) reported quarterly losses of $(0.08) per share. This is a 38.46 percent increase over losses of $(0.13) per share from the same period last year.

VGAS

Verde Clean Fuels Q1 EPS $(0.08) Up From $(0.13) YoY

Biomea Fusion, Inc. ("Biomea") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMEA#NASDAQ">BMEA</a>), a clinical-stage diabetes and obesity medicines company, today announced that preliminary clinical data from the Phase I COVALENT-103 trial of BMF-500 in adults with acute leukemia (AL) were selected for a poster presentation at the European Hematology Association (EHA) 2025 Congress, taking place June 12–15 in Milan, Italy.
The presentation will highlight emerging safety, pharmacokinetics/pharmacodynamics (PK/PD), and clinical activity of BMF-500, a covalent FLT3 inhibitor, in patients with relapsed or refractory (R/R) AL, including those with FLT3 mutations (FLT3m) who have previously received FLT3 inhibitors such as gilteritinib (gilt).

Biotech

General

BMEA

Biomea Fusion's BMF-500 Selected For Poster Presentation At EHA 2025 Highlighting Phase I Data In Relapsed/Refractory Acute Leukemia

Management

AVNT

Avient Board of Directors Appoints Ashish K. Khandpur As Chairman Effective May 14

Steris (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STE#NYSE">STE</a>) reported quarterly earnings of $2.74 per share which beat the analyst consensus estimate of $2.59 by 5.79 percent. This is a 13.69 percent increase over earnings of $2.41 per share from the same period last year. The company reported quarterly sales of $1.48 billion which beat the analyst consensus estimate of $1.47 billion by 0.81 percent. This is a 4.37 percent increase over sales of $1.42 billion the same period last year.

Earnings Beats

Steris Q4 Adj. EPS $2.74 Beats $2.59 Estimate, Sales $1.48B Beat $1.47B Estimate

Dividends

Independence Realty Trust Increases Quarterly Dividend From $0.16 To $0.17

Most women in labor probably don't want their partner to leave them for a <a href="https://www.benzinga.com/personal-finance/25/05/45336434/billionaire-bill-gates-has-a-mcgold-card-that-gives-him-free-mcdonalds-meals-for-life-anywhere-in-the-world-but-says-i-tend-not-to-use-it">conference room and a cheeseburger</a>. But Melinda French Gates? She had a book. And apparently, a high tolerance for both contractions and Microsoft boardrooms.
In her <a href="https://www.facebook.com/share/r/16J2MP4K3u/?mibextid=wwXIfr">new memoir, "The Next Day",</a> French Gates shares a moment from the day her first child, Jennifer, was born—a moment that had the potential to spark social media fury if she hadn't beat everyone to the punchline.
"On the morning of April 26, 1999," she writes, "my water broke." She and Bill made their way to the hospital, only to be told she wasn't quite ready. Doctors even considered sending them home. What followed was a compromise worthy of a marriage negotiation handbook:
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
"Ultimately, we settled on a compromise. I stayed at the hospital. Bill went to the office," she writes. And then, already anticipating the collective eye-roll, she added: "Before you roll your eyes, keep in mind that there really wasn't anything for him to do yet. Plus I had a good book with me."
What could've read as neglectful instead comes off as pragmatic—especially the way Melinda tells it. "In the end, I spent most of that magical day cheerfully alone," she notes, offering zero resentment and plenty of perspective.
But when active labor kicked in, so did the real discomfort—and Bill made it back in time for the action. That's when the cheeseburger incident happened. Melinda recalls asking her husband to remove his sweater "because it smelled like the hamburger he'd eaten on the way, and I was far too nauseated to deal with that."
Her labor lasted more than 14 hours, and at one point, in an effort to avoid a C-section, the doctor attempted a vacuum-assisted delivery. The attempt was brief—and loud. "The doctor [was] shrieking, ‘Turn it off!'" Melinda writes.
Trending: The team behind $6B+ in licensing deals is now building the next billion-dollar IP empire — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">invest early at $2.25/share.</a>
<a href="https://www.benzinga.com/real-estate/25/04/44891233/bill-gates-bought-his-daughter-a-16-million-horse-farm-as-a-graduation-gift-but-ex-wife-melinda-says">Jennifer was finally born</a> at 6:11 p.m., and Melinda describes being "absolutely smitten." It was a transformative moment that marked the beginning of her journey into motherhood in her early 30s—one she now reflects on with clarity, humor, and blunt honesty.
That story—and many others like it—takes on new weight knowing that <a href="https://www.benzinga.com/news/24/09/40852306/melinda-french-gates-embraces-independence-post-divorce-from-bill-gates-it-feels-quite-good">Melinda and Bill finalized their divorce in 2021</a> after nearly three decades of marriage.&nbsp;
She writes that she never expected to become a grandmother before turning 60, but in February 2023, she welcomed granddaughter Leila, followed by Mia just six months later. And just like the day she labored mostly solo while Bill went to work, she's handled this new chapter with grace and a little grit.
"There's a lot that's happened in my life over the last few years that I didn't see coming," she writes in "The Next Day," which was released last month. "During this season, I've seen my life change in ways I hoped for, ways I fought against, and ways I never could have imagined."
It's not the story of a tech titan's wife sitting at home—it's the story of a woman who made space for her own identity, one chapter at a time. And on that first chapter? A good book, some quiet time, and one very unwanted burger-scented sweater.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a></li>
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
</ul>
Image: Shutterstock

Personal Finance

Melinda French Gates Says Bill Went To Work While She Was In Labor With First Baby —'Before You Roll Your Eyes, There Was Nothing For Him To Do Yet'

DXC Technology shares are trading lower after the company reported Q4 financial results and issued Q1 guidance below estimates. Also, the company issued FY26 adjusted EPS guidanc below estimates.

ISSC

Innovative Solns Q2 EPS $0.30 Beats $0.12 Estimate, Sales $21.90M Beat $14.23M Estimate

CSWC

Capital Southwest Q4 EPS $0.61 Misses $0.62 Estimate, Sales $52.40M Miss $52.71M Estimate

Logistic Properties (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LPA#AMEX">LPA</a>) reported $11.84 million in sales this quarter. This is a 12.94 percent increase over sales of $10.48 million the same period last year.

Logistic Properties Q1 Sales $11.84M Up From $10.48M YoY

Kodiak Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOD#NASDAQ">KOD</a>) reported quarterly losses of $(1.09) per share which missed the analyst consensus estimate of $(0.87) by 25.29 percent. This is a 32.93 percent decrease over losses of $(0.82) per share from the same period last year.

Kodiak Sciences Q1 EPS $(1.09) Misses $(0.87) Estimate

Financing

Press Releases

iQIYI Prices Upsized Offering of US$350 Million Convertible Senior Notes due 2030 and Announces Concurrent Repurchases of Approximately $300 Million Convertible Senior Notes

iQIYI Announces the Closing of Its Offering of US$350 Million Convertible Senior Notes due 2030 and Concurrent Repurchase of Approximately US$300 Million Existing Convertible Senior Notes

Entertainment

iQIYI showcases strategic response to TV drama industry trends: short-form content and technological innovation drive growth

iQIYI announces the groundbreaking of its first comprehensive theme park, leveraging IP-driven offline experiences to boost growth

iQIYI hosts Glittering Night to drive high-quality development in mini and short drama industry

iQIYI Files Its Annual Report on Form 20-F

From screen to society: latest iQIYI-presented films champion realism in cinematic storytelling

iQIYI leads agile, IP-and tech-powered offline experience with plan for second theme park in China

iQIYI to Report First Quarter 2025 Financial Results on May 21, 2025

iQIYI 2025 World Conference: Shaping the future of online entertainment through integrated "long + short" storytelling and enhanced IP monetization

AMC Entertainment Holdings, Inc. Class A Common Stock

AMC Entertainment Hldgs

Atlanta Braves Holdings, Inc. - Series A Common Stock

Atlanta Braves Holdings

Atlanta Braves Holdings, Inc. - Series C Common Stock

Cinemark Holdings Inc Cinemark Holdings, Inc. Common Stock

Cinemark Holdings

CuriosityStream Inc. - Class A Common Stock

CuriosityStream

Walt Disney

Liberty Media Corporation - Series A Liberty Formula One Common Stock

Liberty Media

Ordinary Shares (New Liberty Formula One) Series A

Liberty Media Corporation - Series C Liberty Formula One Common Stock

Ordinary Shares (New Liberty Formula One) Series C

Lionsgate Studios

Liberty Media Corporation - Series A Liberty Live Common Stock

Liberty Live

Ordinary Shares (New Liberty Live) Series A

Liberty Media Corporation - Series C Liberty Live Common Stock

Ordinary Shares (New Liberty Live) Series C

Live Nation Entertainment, Inc. Common Stock

Live Nation Entertainment

Manchester United Ltd. Class A Ordinary Shares

Manchester United

Marcus

Madison Square Garden Entertainment Corp. Class A Common Stock

Madison Square Garden

Madison Square Garden Sports Corp. Class A Common Stock (New)

Netflix

Roku

Reservoir Media

Vivid Seats

Sphere Entertainment Co. Class A Common Stock

Sphere Entertainment

TKO Group Holdings, Inc. Class A Common Stock

TKO Group Holdings

Tencent Music Entertainment Group American Depositary Shares, each representing two Class A Ordinary Shares

Comments

iQIYI

iQIYI (IQ) オプション

Loading...

ニュース

パートナーシップ

ベンジンガ・グローバル